EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer

Aneesha Dasgupta iD, Daniel F Gibbard, Rebecca E Schmitt, Paige C Arneson-Wissink iD, Alexandra M Ducharme iD, Elizabeth S Bruinsma iD, John R Hawse iD, Aminah Jatoi, Jason D Doles

Proceedings of the National Academy of Sciences · 22.08.2023 · 120 (34)

DOI: 10.1073/pnas.2215095120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.08.2023. Verfasst von Aneesha Dasgupta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Pancreatic Neoplasms. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAMS NIH HHS, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cachexia, and its associated complications, represent a large and currently untreatable roadblock to effective cancer management. Many potential therapies have been proposed and tested—including appetite stimulants, targeted cytokine blockers, and nutritional supplementation—yet highly effective therapies are lacking. Innovative approaches to treating cancer cachexia are needed. Members of the Kruppel-like factor (KLF) family play wide-ranging and important roles in the development, maintenance, and metabolism of skeletal muscle. Within the KLF family, we identified KLF10 upregulation in a multitude of wasting contexts—including in pancreatic, lung, and colon cancer mouse models as well as in human patients. We subsequently interrogated loss-of-function of KLF10 as a potential strategy to mitigate cancer associated muscle wasting. In vivo studies leveraging orthotopic implantation of pancreas cancer cells into wild-type and KLF10 KO mice revealed significant preservation of lean mass and robust suppression of pro-atrophy muscle-specific ubiquitin ligases Trim63 and Fbxo32, as well as other factors implicated in atrophy, calcium signaling, and autophagy. Bioinformatics analyses identified Transforming growth factor beta (TGF-β), a known inducer of KLF10 and cachexia promoting factor, as a key upstream regulator of KLF10. We provide direct in vivo evidence that KLF10 KO mice are resistant to the atrophic effects of TGF-β. ChIP-based binding studies demonstrated direct binding to Trim63 , a known wasting-associated atrogene. Taken together, we report a critical role for the TGF-β/KLF10 axis in the etiology of pancreatic cancer–associated muscle wasting and highlight the utility of targeting KLF10 as a strategy to prevent muscle wasting and limit cancer-associated cachexia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor betaPancreatic NeoplasmsHumansMiceAnimalsCachexiaMuscular AtrophyKruppel-Like Transcription FactorsMuscle, SkeletalEarly Growth Response Transcription Factors

Stichwörter der Autor:innen

KLF10TGF-βcachexiamuscle wastingpancreatic cancer

Substanzen

Transforming Growth Factor betaKruppel-Like Transcription FactorsKLF10 protein, humanEarly Growth Response Transcription FactorsKLF10 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905.
  • Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202.
  • Indiana Center for Musculoskeletal Health, Indianapolis, IN 46202.
  • Tumor Microenvironment & Metastasis Program, Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN 46202.
  • Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905.
  • Department of Oncology, Mayo Clinic, Rochester, MN 55905.

ORCID-Profile: Aneesha Dasgupta, Paige C Arneson-Wissink, Alexandra M Ducharme, Elizabeth S Bruinsma, John R Hawse

Förderung

  • NCI NIH HHS
  • NIAMS NIH HHS
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • HHS | NIH | National Cancer Institute
  • American Association for Cancer Research

Zitieren

APA

Dasgupta, A., Gibbard, D. F., Schmitt, R. E., Arneson-Wissink, P. C., Ducharme, A. M., Bruinsma, E. S., Hawse, J. R., Jatoi, A., & Doles, J. D. (2023). A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer. Proceedings of the National Academy of Sciences, 120(34). https://doi.org/10.1073/pnas.2215095120

Vancouver

Dasgupta A, Gibbard DF, Schmitt RE, Arneson-Wissink PC, Ducharme AM, Bruinsma ES, et al. A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer. Proceedings of the National Academy of Sciences. 2023;120(34). doi:10.1073/pnas.2215095120

BibTeX
@article{Dasgupta2023,
  author = {Dasgupta, Aneesha and Gibbard, Daniel F and Schmitt, Rebecca E and Arneson-Wissink, Paige C and Ducharme, Alexandra M and Bruinsma, Elizabeth S and Hawse, John R and Jatoi, Aminah and Doles, Jason D},
  title = {A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {34},
  doi = {10.1073/pnas.2215095120}
}
Kostenlos starten →